Literature DB >> 16135490

Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.

Marco Maltoni1, Augusto Caraceni, Cinzia Brunelli, Bert Broeckaert, Nicholas Christakis, Steffen Eychmueller, Paul Glare, Maria Nabal, Antonio Viganò, Philip Larkin, Franco De Conno, Geoffrey Hanks, Stein Kaasa.   

Abstract

PURPOSE: To offer evidence-based clinical recommendations concerning prognosis in advanced cancer patients.
METHODS: A Working Group of the Research Network of the European Association for Palliative Care identified clinically significant topics, reviewed the studies, and assigned the level of evidence. A formal meta-analysis was not feasible because of the heterogeneity of published studies and the lack of minimal standards in reporting results. A systematic electronic literature search within the main available medical literature databases was performed for each of the following four areas identified: clinical prediction of survival (CPS), biologic factors, clinical signs and symptoms and psychosocial variables, and prognostic scores. Only studies on patients with advanced cancer and survival < or = 90 days were included.
RESULTS: A total of 38 studies were evaluated. Level A evidence-based recommendations of prognostic correlation could be formulated for CPS (albeit with a series of limitations of which clinicians must be aware) and prognostic scores. Recommendations on the use of other prognostic factors, such as performance status, symptoms associated with cancer anorexia-cachexia syndrome (weight loss, anorexia, dysphagia, and xerostomia), dyspnea, delirium, and some biologic factors (leukocytosis, lymphocytopenia, and C-reactive protein), reached level B.
CONCLUSION: Prognostication of life expectancy is a significant clinical commitment for clinicians involved in oncology and palliative care. More accurate prognostication is feasible and can be achieved by combining clinical experience and evidence from the literature. Using and communicating prognostic information should be part of a multidisciplinary palliative care approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135490     DOI: 10.1200/JCO.2005.06.866

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  160 in total

1.  Development of a prognostic model for six-month mortality in older adults with declining health.

Authors:  Paul K J Han; Minjung Lee; Bryce B Reeve; Angela B Mariotto; Zhuoqiao Wang; Ron D Hays; K Robin Yabroff; Marie Topor; Eric J Feuer
Journal:  J Pain Symptom Manage       Date:  2011-11-08       Impact factor: 3.612

2.  Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium.

Authors:  Emanuela Scarpi; Marco Maltoni; Rosalba Miceli; Luigi Mariani; Augusto Caraceni; Dino Amadori; Oriana Nanni
Journal:  Oncologist       Date:  2011-10-31

3.  Symptom clusters and prognosis in advanced cancer.

Authors:  Aynur Aktas; Declan Walsh; Lisa Rybicki
Journal:  Support Care Cancer       Date:  2012-02-24       Impact factor: 3.603

4.  Prospective comparison of prognostic scores in palliative care cancer populations.

Authors:  Marco Maltoni; Emanuela Scarpi; Cristina Pittureri; Francesca Martini; Luigi Montanari; Elena Amaducci; Stefania Derni; Laura Fabbri; Marta Rosati; Dino Amadori; Oriana Nanni
Journal:  Oncologist       Date:  2012-02-29

5.  Chemotherapy in patients with advanced pancreatic cancer: too close to death?

Authors:  M Frigeri; S De Dosso; O Castillo-Fernandez; K Feuerlein; H Neuenschwander; P Saletti
Journal:  Support Care Cancer       Date:  2012-06-01       Impact factor: 3.603

Review 6.  Chemotherapy at end-of-life: an integration of oncology and palliative team.

Authors:  Wing-lok Chan; Ka-on Lam; Wai-kwan Siu; Kwok-keung Yuen
Journal:  Support Care Cancer       Date:  2015-11-25       Impact factor: 3.603

7.  The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.

Authors:  Yoshiaki Ikuta; Hiroshi Takamori; Yasuo Sakamoto; Daisuke Hashimoto; Akira Chikamoto; Hideyuki Kuroki; Kazuya Sakata; Keita Sakamoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Masahiko Hirota; Keiichiro Kanemitsu; Toru Beppu; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2013-09-03       Impact factor: 3.402

8.  Frequency and factors associated with unexpected death in an acute palliative care unit: expect the unexpected.

Authors:  Sebastian Bruera; Gary Chisholm; Renata Dos Santos; Eduardo Bruera; David Hui
Journal:  J Pain Symptom Manage       Date:  2014-12-11       Impact factor: 3.612

Review 9.  The challenges of managing cancer related venous thromboembolism in the palliative care setting.

Authors:  S Noble
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

10.  Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.

Authors:  Kohei Shitara; Satoshi Yuki; Kentaro Yamazaki; Yoichi Naito; Hiraku Fukushima; Yoshito Komatsu; Hirofumi Yasui; Toshimi Takano; Kei Muro
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.